Patients in cardiogenic shock with significant mitral regurgitation (MR) appear to fare well in the short term when treated with transcatheter edge-to-edge repair (TEER), according to a new ...
BOSTON, MA—(UPDATED) Patients with severe symptomatic degenerative mitral regurgitation (MR) ineligible for surgery fare just as well when treated with the Pascal device (Edwards Lifesciences) as ...
LONDON -- Despite another positive trial, controversy rages on over transcatheter edge-to-edge repair (TEER or M-TEER) in people with symptomatic heart failure (HF) and functional mitral regurgitation ...
Failed transcatheter edge-to-edge repair of functional and degenerative mitral regurgitation (MR) with the MitraClip (Abbott) is relatively uncommon at high-volume centers but associated with a high ...
It’s been a long time since Ernie Hoffman, an 86-year-old Mesquite, Nevada resident, could climb a flight of stairs without pausing midway to catch his breath; or even eat a regular meal without ...
With significant advancements in heart treatment, the days of open-heart surgery as the only option for complex heart conditions are mostly behind us. Today, minimally invasive procedures can be used ...
NEW ORLEANS — To much acclaim, the COAPT trial demonstrated that use of the MitraClip (Abbott) in a very sick population with symptomatic (heart failure (HF) and secondary mitral regurgitation (MR) ...
NEW YORK (Reuters) - An experimental minimally invasive technique developed by Abbott Laboratories to repair the most common type of heart valve problem appeared to be as durable as surgical repair ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results